Rosiglitazone protects the pancreatic β-cell death induced by cyclosporine A

Biochemical and Biophysical Research Communications

Volumn 390, Issue 3, 2009, Pages 763-768

  Kim, Ji Won ^a   Yang, Ji Hun ^a   Park, Heon Seok ^a   Sun, Chenglin ^a   Lee, Seung Hwan ^a   Cho, Jae Hyoung ^a   Yang, Chul Woo ^a   Yoon, Kun Ho ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Cyclosporine A; ER stress; Pancreatic cells; Rosiglitazone

Indexed keywords

CYCLOSPORIN A; GLUCOSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; ROSIGLITAZONE; X BOX BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DETERIORATION; DIABETES MELLITUS; ENDOPLASMIC RETICULUM STRESS; GLUCOSE TOLERANCE; MALE; NONHUMAN; PANCREAS INSUFFICIENCY; PANCREAS ISLET BETA CELL; POSTTRANSPLANT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CYCLOSPORINE; CYTOPROTECTION; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN-SECRETING CELLS; MALE; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLIDINEDIONES; TRANSPLANTATION;

EID: 70449732103     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.10.046     Document Type: Article

References (27)

1. Bierer B.E., Holländer G., Fruman D., and Burakoff S.J. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr. Opin. Immunol. 5 (1993) 763-773
2. Duclos A., Flechner L.M., Faiman C., and Flechner S.M. Post-transplant diabetes mellitus: risk reduction strategies in the elderly. Drugs Aging 23 (2006) 781-793
3. First M.R., Gerber D.A., Hariharan S., Kaufman D.B., and Shapiro R. Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management. Transplantation 73 (2002) 379-386
4. Ishizuka J., Gugliuzza K.K., Wassmuth Z., Hsieh J., Sato K., Tsuchiya T., Townsend C.M., Fish J.C., and Thompson J.C. Effects of FK506 and cyclosporine on dynamic insulin secretion from isolated dog pancreatic islets. Transplantation 56 (1993) 1486-1490
5. Ajabnoor M.A., El-Naggar M.M., Elayat A.A., and Abdulrafee A. Functional and morphological study of cultured pancreatic islets treated with cyclosporine. Life Sci. 80 (2007) 345-355
6. Ortsäter H., and Sjöholm A. A busy cell-endoplasmic reticulum stress in the pancreatic beta-cell. Mol. Cell. Endocrinol. 277 (2007) 1-5
7. Eizirik D.L., Cardozo A.K., and Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr. Rev. 29 (2008) 42-61
8. Laybutt D.R., Preston A.M., Akerfeldt M.C., Kench J.G., Busch A.K., Biankin A.V., and Biden T.J. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes. Diabetologia 50 (2007) 752-763
9. Marchetti P., Bugliani M., Lupi R., Marselli L., Masini M., Boggi U., Filipponi F., Weir G.C., Eizirik D.L., and Cnop M. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia 50 (2007) 2486-2494
10. Chung B.H., Li C., Sun B.K., Lim S.W., Ahn K.O., Yang J.H., Choi Y.H., Yoon K.H., Sugawara A., Ito S., Kim J., and Yang C.W. Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats. Am. J. Transplant. 5 (2005) 1856-1867
11. Weibel E.R. Stereologic methods. Practical Methods for Biologic Morphometry vol. 1 (1978), Academic Press, London 101-161
12. Bonner-Weir S. Beta-cell turnover: its assessment and implications. Diabetes 50 (2001) S20-S24
13. Attardi L.D., and Tjian R. Drosophila tissue-specific transcription factor NTF-1 contains a novel isoleucine-rich activation motif. Genes Dev. 7 (1993) 1341-1353
14. Robertson R.P. Islet transplantation as a treatment for diabetes-a work in progress. N. Engl. J. Med. 350 (2004) 694-705
15. Wajchenberg B.L. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr. Rev. 28 (2007) 187-218
16. Campbell I.W., and Mariz S. Beta-cell preservation with thiazolidinediones. Diabetes Res. Clin. Pract. 76 (2007) 163-176
17. Kim H.S., Noh J.H., Hong S.H., Hwang Y.C., Yang T.Y., Lee M.S., Kim K.W., and Lee M.K. Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2/NeuroD expression. Biochem. Biophys. Res. Commun. 367 (2008) 623-629
18. Richardson H., Campbell S.C., Smith S.A., and Macfarlane W.M. Effects of rosiglitazone and metformin on pancreatic beta cell gene expression. Diabetologia 49 (2006) 685-696
19. Kawasaki F., Matsuda M., Kanda Y., Inoue H., and Kaku K. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice. Am. J. Physiol. Endocrinol. Metab. 288 (2005) E510-E518
20. Kim E.K., Kwon K.B., Koo B.S., Han M.J., Song M.Y., Song E.K., Han M.K., Park J.W., Ryu D.G., and Park B.H. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway. Int. J. Biochem. Cell Biol. 39 (2007) 1260-1275
21. Saitoh Y., Liu R., Ueno H., Mizuta M., and Nakazato M. Oral pioglitazone administration increases food intake through ghrelin-independent pathway in Zucker fatty rat. Diabetes Res. Clin. Pract. 77 (2007) 351-356
22. Fonseca S.G., Lipson K.L., and Urano F. Endoplasmic reticulum stress signaling in pancreatic beta-cells. Antioxid. Redox Signal. 9 (2007) 2335-23444
23. Jiang H.Y., and Wek R.C. Phosphorylation of the alpha-subunit of the eukaryotic initiation factor-2 (eIF2alpha) reduces protein synthesis and enhances apoptosis in response to proteasome inhibition. J. Biol. Chem. 280 (2005) 14189-14202
24. Justo P., Lorz C., Sanz A., Egido J., and Ortiz A. Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. J. Am. Soc. Nephrol. 14 (2003) 3072-3080
25. Villanueva G., and Baldwin D. Rosiglitazone therapy of posttransplant diabetes mellitus. Transplantation 80 (2005) 1402-1405
26. Hsu B.R., Fu S.H., Ku K.W., Yang T.Y., Juang J.H., and Chen S.T. Enhancing islet engraftment with rosiglitazone. Transplant. Proc. 37 (2005) 245-247
27. Merani S., and Shapiro A.M. Current status of pancreatic islet transplantation. Clin. Sci. 110 (2006) 611-625